NACL Industries Ltd

NACL Industries Ltd

₹ 53.1 -0.15%
04 Dec 2:02 p.m.
About

NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]

Key Points

Products[1]
Key technicals:
Insecticides: Cairo, Fenny, Nagarjuna 4G, PestLock, etc.
Herbicides: Font, Slogan, Nagarjuna Combi plus, etc.
Fungicides: Combi plus, Kazan, Result, Subtle Plant Growth Regulators :Atonik, Gallant EG, Gallant Gold
Company has 63 branded products.[2]

  • Market Cap 1,060 Cr.
  • Current Price 53.1
  • High / Low 85.0 / 48.6
  • Stock P/E
  • Book Value 26.2
  • Dividend Yield 0.00 %
  • ROCE -0.17 %
  • ROE -8.50 %
  • Face Value 1.00

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 8.67% over last 3 years.
  • Company has high debtors of 160 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
443 400 471 475 565 483 597 386 587 354 454 334 448
401 369 431 442 511 445 527 418 557 352 447 342 412
Operating Profit 42 31 40 33 54 38 70 -32 30 1 7 -9 36
OPM % 9% 8% 8% 7% 10% 8% 12% -8% 5% 0% 2% -3% 8%
5 5 3 3 4 2 3 3 1 2 4 4 2
Interest 7 8 8 9 12 12 11 15 15 16 14 15 13
Depreciation 6 6 6 7 7 6 6 4 5 5 5 5 4
Profit before tax 34 21 28 20 40 22 56 -49 11 -17 -7 -24 20
Tax % 26% 28% 25% 26% 25% 26% 25% -25% 23% -23% -24% -25% 27%
25 15 21 15 30 16 42 -37 9 -13 -6 -18 14
EPS in Rs 1.28 0.78 1.06 0.76 1.51 0.81 2.09 -1.84 0.43 -0.66 -0.29 -0.92 0.72
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
601 636 746 691 734 846 865 1,015 1,191 1,633 2,116 1,781 1,590
583 625 701 635 678 797 852 946 1,078 1,492 1,920 1,774 1,554
Operating Profit 18 11 44 56 56 49 14 69 113 141 196 6 36
OPM % 3% 2% 6% 8% 8% 6% 2% 7% 10% 9% 9% 0% 2%
18 16 26 18 41 19 26 7 15 16 12 10 12
Interest 31 28 35 37 38 33 34 29 29 30 44 60 58
Depreciation 25 22 25 27 28 20 20 24 25 25 26 18 19
Profit before tax -20 -23 10 11 31 15 -15 23 74 102 138 -62 -29
Tax % -36% -9% 27% 17% -4% 26% -44% 31% 32% 26% 25% -24%
-13 -21 8 9 32 11 -8 16 50 76 103 -47 -23
EPS in Rs -0.70 -1.36 0.49 0.58 2.03 0.69 -0.50 0.82 2.56 3.83 5.17 -2.36 -1.15
Dividend Payout % 0% 0% 20% 17% 6% 18% 0% 12% 16% 14% 14% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 16%
3 Years: 14%
TTM: -23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -177%
Stock Price CAGR
10 Years: 14%
5 Years: 15%
3 Years: -8%
1 Year: -29%
Return on Equity
10 Years: 7%
5 Years: 9%
3 Years: 9%
Last Year: -9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 15 16 16 16 16 16 17 19 20 20 20 20 20
Reserves 180 158 161 168 210 219 262 331 392 464 558 507 504
177 219 228 232 213 237 210 268 202 446 580 648 390
228 227 260 193 209 237 248 330 354 486 595 494 605
Total Liabilities 600 620 664 609 648 709 737 948 968 1,415 1,752 1,669 1,519
172 182 176 167 163 158 141 191 191 209 212 238 254
CWIP 11 18 12 6 7 5 21 42 35 21 40 26 15
Investments 4 8 10 10 5 5 9 9 30 78 107 114 114
413 411 466 426 473 541 566 706 712 1,107 1,393 1,290 1,136
Total Assets 600 620 664 609 648 709 737 948 968 1,415 1,752 1,669 1,519

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
76 31 40 46 59 24 36 103 84 -116 -10 26
-5 -47 -18 -12 -6 -14 -27 -97 -17 -111 -74 -38
-74 11 -27 -33 -58 -11 -9 70 -84 204 79 4
Net Cash Flow -3 -5 -4 1 -5 -1 0 77 -17 -22 -5 -8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 100 92 108 99 110 124 113 129 103 118 133 160
Inventory Days 154 140 138 153 189 143 144 90 106 132 117 91
Days Payable 113 97 121 89 127 129 134 146 128 120 113 85
Cash Conversion Cycle 141 135 125 163 172 137 123 73 82 130 137 166
Working Capital Days 97 93 90 119 126 125 125 90 90 124 127 148
ROCE % 3% 2% 11% 12% 10% 11% 4% 9% 17% 17% 18% -0%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
64.16% 64.00% 63.97% 63.97% 63.97% 63.83% 63.83% 63.83% 63.80% 63.72% 63.65% 63.65%
1.85% 1.87% 1.85% 1.87% 1.50% 1.20% 1.16% 1.03% 0.50% 0.28% 0.31% 0.18%
0.00% 0.00% 0.00% 0.00% 0.23% 0.47% 0.81% 0.96% 0.96% 0.96% 0.89% 0.00%
33.99% 34.13% 34.18% 34.14% 34.30% 34.49% 34.20% 34.18% 34.75% 35.04% 35.15% 36.16%
No. of Shareholders 21,64522,85524,07423,91123,65522,95222,44824,81026,94230,81429,56733,089

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls